RaineA.E., MargreiterR., BrunnerF.D.Report on management of renal failure in Europe XXII, 1991. Nephrol Dial Transplant1992; 7(suppl 2): S7–35.
2.
WilckenD.E., GuptaV.J.Sulpher containing amino acids in chronic renal failure with particular reference to homocysteine and cysteine-homocysteine mixed disulphide. Eur J Clin Invest1979; 9: 301–7.
3.
MoustaphaA., NasoA., NahlawiM., GuptaA., ArheartK.L., JacobsenD.W., RobinsonK., DennisV.W.Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation1998; 97: 138–41.
ArnadottirM., HultbergB., WahlbergJ., FellstromB., DimenyE.Influence of hemodialysis on plasma total homocysteine concentration. Nephrol Dial Transplant1999; 14: 142–6.
6.
HouseA.A., WellsG.A., DonnellyJ.G., NadlerS.P., HebertP.C.Randomized trial of high-flux vs low flux haemodialysis effects on homocysteine and lipids. Nephrol Dial Transplant2000; 15: 1029–34.
7.
van TellingenA., GrootemanM.P.C., CM BartelsP.C.M., van LimbeekJ., van GuldenerC., ter WeeP.M., NubéM.J.Long-term reduction of plasma homocysteine levels by super-flux dialyzers in hemodialysis patients. Kidney Int2001; 59: 342–7.
MuddS.H., PooleJ.R.Labile methyl balances for normal humans on various dietary regimens. Metabolism1975; 24: 721–35.
10.
Van GuldenerC., KulikW., BergerR., DijkstraD.A., JakobsC., ReijngoudD.J., DonkerA.J., StehouwerC.D., de MeerK.Homocysteine and methionine metabolism in ESRD: A stable isotope study. Kidney Int1999; 56: 1064–71.
11.
HenningB.F., RiezlerR., TepelM., LangerK., RaidtH., GraefeU., ZidekW.Evidence of alterated homocysteine metabolism in chronic renal failure. Nephron1999; 83: 314–22.
12.
AmoreA., CirinaP., MitolaS., PeruzziL., BonaudoR., GianoglioB, and CoppoR.Acetate intolerance is mediated by enhanced synthesis of nitric oxide by endothelial cells. J Am Soc Nephrol1997; 8: 1431–6.
